Subcutaneous Fat Necrosis During Nivolumab Therapy for Metastatic Melanoma. uri icon

Overview

publication date

  • April 1, 2021

Research

keywords

  • Antineoplastic Agents, Immunological
  • Melanoma
  • Nivolumab
  • Skin Neoplasms
  • Subcutaneous Fat

Identity

Scopus Document Identifier

  • 85102454766

Digital Object Identifier (DOI)

  • 10.1001/jamadermatol.2021.0058

PubMed ID

  • 33688919

Additional Document Info

volume

  • 157

issue

  • 4